[1]Patent:US2007/275906,2007,A1.Locationinpatent:Page/Pagecolumn15;26;97-98
[1]Patent:WO2008/97676,2008,A1.Locationinpatent:Page/Pagecolumn24-25
15027-14-2
181227-47-4
198473-94-8
201677-20-5
190004-53-6
2640-58-6
1391054-02-6 | Vigabatrin Hydrochloride | AA001A7H | MFCD28142357
1392804-87-3 | (5,8-Dioxa-spiro[3.4]oct-2-yl)methylamine | AA001ALA | MFCD23106176
13949-67-2 | 2-(Naphthalen-1-yloxy)propanoic acid | AA001B26 | MFCD00021470
13980-77-3 | 5H-Tetrazole-5-thione, 1,2-dihydro-1-(4-methylphenyl)- | AA001BN0 | MFCD00498983
1400580-54-2 | 3,3-Dimethyloxan-4-amine hydrochloride | AA001BWG | MFCD28155170
1404-88-2 | TYROTHRICIN | AA001CAA | MFCD00082120
1408058-17-2 | 4-Fluoro-1h-indazole-7-carbonitrile | AA001CPG | MFCD22574991
1454690-80-2 | 2-[1-(Trifluoromethyl)cyclopropyl]ethan-1-amine hydrochloride | AA001CZ0 | MFCD29918543
145742-38-7 | 2-(Cyclopentyloxy)benzaldehyde | AA001DAA | MFCD04132910
146059-77-0 | 5-(Hydroxymethyl)piperidin-2-one | AA001DKC | MFCD13178756